Alexion Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,515
1,962
1,385
1,293
1,474
1,564
Total Accounts Receivable
444
433
533
650
727
922
Inventories
103
176
290
375
460
473
Other Current Assets
126
225
208
260
293
426
Total Current Assets
2,187
2,796
2,416
2,578
2,954
3,385
Net Property, Plant & Equipment
201
392
697
1,036
1,325
1,472
Total Investments and Advances
-
38
-
-
-
-
Intangible Assets
864
841
9,756
9,340
8,992
8,679
Other Assets
63
100
228
299
312
396
Total Assets
3,318
4,202
13,097
13,253
13,583
13,932
ST Debt & Current Portion LT Debt
48
48
166
167
167
Accounts Payable
22
44
57
64
71
Other Current Liabilities
513
515
486
592
714
Total Current Liabilities
582
607
709
823
953
Long-Term Debt
65
10
3,254
2,888
2,721
Provision for Risks & Charges
139
224
121
129
169
Deferred Taxes
98
28
529
396
365
Other Liabilities
48
53
225
323
483
Total Liabilities
936
900
4,838
4,559
4,690
Common Equity (Total)
2,382
3,302
8,259
8,694
8,893
Total Shareholders' Equity
2,382
3,302
8,259
8,694
8,893
Total Equity
2,382
3,302
8,259
8,694
8,893
Liabilities & Shareholders' Equity
3,318
4,202
13,097
13,253
13,583
About Alexion Pharmaceuticals
View Profile
